MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment.
- 1 October 1987
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 165 (1) , 215-219
- https://doi.org/10.1148/radiology.165.1.3628774
Abstract
Magnetic resonance (MR) image-guided phosphorus-31 MR spectra have been obtained from in situ brain tumors. The volumes of interest used for spectroscopy were defined from hydrogen-1 MR images. Direct comparisons were possible between normal and abnormal tissue, since P-31 spectra from different parts of the brain could be measured in a single examination. P-31 MR spectra of the tumors often showed abnormally high concentrations of phosphomonoesters and low concentrations of phosphocreatines. The effects of pharmacotherapy and radiation therapy were studied in three patients; in each of these cases changes were observed in the P-31 spectra of the tumor. The correlation between MR imaging and P-31 MR spectroscopy was essential for the interpretations of these results.This publication has 6 references indexed in Scilit:
- Extremity bone tumors: evaluation by P-31 MR spectroscopy.Radiology, 1985
- Cerebral intracellular pH by 31 P nuclear magnetic resonance spectroscopyNeurology, 1985
- Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla.Radiology, 1984
- Cerebral metabolic studies in vivo by 31P NMR.Proceedings of the National Academy of Sciences, 1983
- Localization of metabolites in animals using 31P topical magnetic resonanceNature, 1980
- Mapping of metabolites in whole animals by 31P NMR using surface coilsNature, 1980